Drug Trial Radar · NCT04041648
Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606
Last checked: Nov 19, 2026Latest source record: Aug 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
Nov 9, 2018
Primary completion
Sep 20, 2019
Study completion May 12, 2020
Sponsor
- Lead sponsor
- Pharmosa Biopharm Inc.Industry
- Sponsor type
- Industry
- Collaborators
- PPD Development, LP
- First posted
- Aug 1, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the Pharmacokinetics, Safety and Tolerability of L606 (Liposomal Treprostinil) Inhalation Solution in Single Ascending Dose study design in healthy volunteers.
Conditions
- Pulmonary Arterial Hypertension
Interventions
L606 (Liposomal Treprostinil) Inhalation Solution 51ugDrug
Single ascending dose
L606 Inhalation SystemDevice
Single ascending dose
Placebo SolutionOther
Single ascending dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number of treatment-emergent adverse events for L606 and placebo, including abnormal laboratory eventsTime frame: From Pre-dose to Day 10
Locations
1 site in 1 country. Site status is shown where the registry gives one.
PPD
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.